Scott Henry
Stock Analyst at Alliance Global Partners
(1.63)
# 3,162
Out of 4,843 analysts
61
Total ratings
37.74%
Success rate
-4.58%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.08 | +177.78% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.68 | +123.21% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $2.42 | +147.93% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.38 | +195.86% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.66 | +313.97% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $8.01 | +6.12% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.40 | +185.71% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.89 | +693.65% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.97 | +1,136.86% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $5.90 | +27.12% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $16.21 | -19.80% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $26.80 | -10.45% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $102.19 | -11.93% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $24.96 | -37.90% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $82.20 | -29.44% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $57.88 | -37.80% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.00 | +1,002.20% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.79 | +25.26% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.49 | +230,823.69% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.67 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $2.97 | +135.69% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $39.78 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.55 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.60 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.08
Upside: +177.78%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.68
Upside: +123.21%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $2.42
Upside: +147.93%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.38
Upside: +195.86%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.66
Upside: +313.97%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $8.01
Upside: +6.12%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.40
Upside: +185.71%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.89
Upside: +693.65%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.97
Upside: +1,136.86%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $5.90
Upside: +27.12%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $16.21
Upside: -19.80%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $26.80
Upside: -10.45%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $102.19
Upside: -11.93%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $24.96
Upside: -37.90%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $82.20
Upside: -29.44%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $57.88
Upside: -37.80%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.00
Upside: +1,002.20%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.79
Upside: +25.26%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.49
Upside: +230,823.69%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $3.67
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $2.97
Upside: +135.69%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $39.78
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.55
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $4.60
Upside: -